Goldman Sachs Maintains Buy on Legence, Raises Price Target to $63

Goldman Sachs analyst Adam Bubes has maintained a Buy rating on Legence (NASDAQ: LGN) and increased the price target from $52 to $63. This adjustment reflects a positive outlook for the company's performance.